歐聖電氣(301187.SZ):擬向歐聖工業增資6500萬美元 將新建倉庫、車間及注塑、裝配生產線項目
格隆匯9月22日丨歐聖電氣(301187.SZ)公佈,公司擬以現金向境外(美國)全資子公司歐聖工業集團有限公司(簡稱“歐聖工業”)增資6500萬美元,約合人民幣4.6億元(1美元≈7.06人民幣)。本次增資完成後,歐聖工業註冊資本將增加至6970.1萬美元。增資完成後,歐聖工業將在美國內華達州克拉克縣亨德森市新建倉庫、車間及注塑、裝配生產線項目,該項目佔地面積約26,477平米,總建築面積約29,264平米,其中用於倉儲的面積約佔18,580平米,用於生產的面積約佔9,290平米。項目達產後,預計年產真空吸塵器95萬套,護理機器人2,400套。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.